Health LibraryHealth Librarybrought to you by therapy training school
 







Health Issues :: Acid Reflux
A useful resource of articles and advice relating to all aspects of acid reflux and related problems.
therapy training courses


Latest Articles
Greatly Increased Risk Of Reflux Disease Of Esophagus In Extremely Obese Children
Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease (GERD) and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity...
Sat, 10 Jul 2010 00:00:00 PDT

Obese Children At Higher Risk Of GERD
A large US study found that compared to normal weight children, obese children have a higher risk of developing gastroesophageal reflux disease (GERD), a condition where stomach fluid flows up into the food pipe or esophagus, damaging the lining and possibly also raising the incidence of inflammation, asthma and coughs...
Fri, 09 Jul 2010 11:00:00 PDT

Origin Of Acid Reflux Disease Revealed By Molecular Imaging
Molecular imaging has uncovered what may be to blame for acid reflux disease, a painful and potentially dangerous illness that affects a sizeable percentage of the population...
Tue, 08 Jun 2010 02:00:00 PDT

FDA Accepts New Drug Application (NDA) For Rabeprazole Sodium Extended-Release 50 Mg For Patients With Gastroesophageal Reflux Disease (GERD)
Eisai Inc. (Headquarters: Woodcliff Lake, NJ; Chairman and CEO: Hajime Shimizu), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) announced that the U.S...
Fri, 04 Jun 2010 01:00:00 PDT

Axanum And Expanded Nexium Indication Rejected By FDA
The Food and Drug Administration (FDA), USA has denied approval of AstraZeneca's Axanum (aspirin plus esomeprazole magnesium) and an expanded indication for AstraZeneca's Nexium (esomeprazole magnesium). AstraZeneca received a CRL (Complete Response Letter) for the new drug application for Axanum tablets, as well as a CRL for the supplemental new drug application (sNDA) for Nexium...
Tue, 01 Jun 2010 09:00:00 PDT


Copyright © 2010 Therapy Training School | Sitemap | Designed by WebZen